Advertisement

Topics

Aerie Pharmaceuticals Company Profile

00:29 EDT 23rd June 2018 | BioPortfolio

Aerie Pharmaceuticals is a privately held, clinical-stage biotechnology company dedicated to the discovery and development of novel treatments for glaucoma. Aerie’s internal research and development engine has generated an innovative glaucoma pipeline. The Company’s lead product candidate, AR-12286, is a highly selective Rho-kinase (ROCK) inhibitor designed to lower intraocular pressure by improving outflow of fluid via the trabecular pathway with the potential of restoring normal function. Aerie currently is evaluating AR-12286 in multiple Phase 2 clinical studies as a standalone therapy and in combination with a commercially available prostaglandin. In addition, the Company is in Phase 2 clinical development for AR-13324, a novel product candidate with a dual mechanism of action that represents the first of a new proprietary class of glaucoma drugs. The Company is located in Bedminster, New Jersey and Research Triangle Park, North Carolina.


News Articles [522 Associated News Articles listed on BioPortfolio]

Aerie seeks FDA nod for eye drop

A marketing application was filed with the FDA by Aerie Pharmaceuticals for its once-daily eyedrop Roclatan, or netarsudil/la -More- 

Aerie Pharmaceuticals Submits New Drug Application For Roclatan

NewsRoclatan is a once-daily eye drop designed to reduce intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.

Aerie Pharmaceuticals Launches Rhopressa In The U.S.

NewsRhopressa (netarsudil ophthalmic solution) 0.02% is a once-daily eye drop for the lowering of elevated intraocular pressure in patients with glaucoma and ocular hypertension, and was approved by t...

Aerie Pharmaceuticals Submits NDA to FDA for Roclatan (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%

DURHAM, N.C.--(BUSINESS WIRE)--May 15, 2018-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-cl...

Former Allergan exec to ensure Aerie gets vital launch right

Ophthalmic drug specialist Aerie Pharmaceuticals has appointed Julia Williams as director of medical…

VIDEO: Aerie pipeline evolving in glaucoma, retina treatments

WASHINGTON ― At the Ophthalmology Innovation Summit at ASCRS here, Tom Mitro, president and COO of Aerie Pharmaceuticals, discusses the company’s pipeline in glaucoma as well as retinal disease tr...

VIDEO: Aerie ramps up marketing for Rhopressa

SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Tom Mitro, president and chief operating officer of Aerie Pharmaceuticals, discusses the build-out the company is performing to ramp up for t...

Aerie to match ASCRS Foundation donations during annual meeting

WASHINGTON – Aerie Pharmaceuticals will match up to $25,000 of donations made to the ASCRS Foundation during the annual ASCRS meeting, the company announced in a press release.The ASCRS Foundation, ...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [133 Associated PubMed Articles listed on BioPortfolio]

Netarsudil Ophthalmic Solution 0.02%: First Global Approval.

Netarsudil ophthalmic solution 0.02% (hereafter referred to as netarsudil 0.02%) [Rhopressa] is a Rho-associated protein kinase inhibitor that is thought to lower intraocular pressure (IOP) by increas...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Clinical Trials [216 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1324 Associated Companies listed on BioPortfolio]

Aerie Pharmaceuticals, Inc.

Aerie Pharmaceuticals is a privately held pharmaceutical company in late Phase 2 dedicated to the discovery and development of novel small-molecule treatments for glaucoma. Aerie...

Aerie Pharmaceuticals

Aerie Pharmaceuticals is a privately held, clinical-stage biotechnology company dedicated to the discovery and development of novel treatments for glaucoma. Aerie’s internal ...

American Eagle Outfitters

American Eagle Outfitters (NYSE: AEO) is a leading global specialty retailer offering high-quality, on-trend clothing, accessories and personal care products at affordable prices ...

American Eagle Outfitters, Inc.

American Eagle Outfitters, Inc. (NYSE: AEO) is a leading global specialty retailer offering high- quality, on-trend clothing, accessories and personal care products at affordable ...

MSRS/Aerie Corporation

Each primary antibody record contains 11 fields including antibody, host, antigen species, label, form, clone number, isotype, unit size, product number, specifications and supplier name. Each listing...

More Information about "Aerie Pharmaceuticals" on BioPortfolio

We have published hundreds of Aerie Pharmaceuticals news stories on BioPortfolio along with dozens of Aerie Pharmaceuticals Clinical Trials and PubMed Articles about Aerie Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aerie Pharmaceuticals Companies in our database. You can also find out about relevant Aerie Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record